Background

Psychosocial factors are useful predictors of adverse outcomes after solid organ transplantation. Although depression is a known predictor of poor outcomes in patients who undergo orthotopic heart transplantation (OHT) and is actively screened for during pre-transplant evaluation, the effects of early identification of this entity on post-transplant outcomes are not clearly understood. The purpose of this study was to evaluate the impact of pre-transplant depression on outcomes after OHT.

Method

In this retrospective study, 51 patients that underwent psychosocial evaluation performed by a social worker prior to the transplant and followed up in our center post-transplant were enrolled. Patients were stratified by the presence/absence of depression during the initial encounter. Primary end-points were overall survival, 1st-year hospitalizations, overall hospitalizations, rejections, and compliance with medications and outpatient appointments.

Conclusion

Depression was a strong predictor of poor medication compliance and higher rates of hospitalization in transplant recipients. No difference in survival between depressed and non-depressed patients after OHT was noted.

Depression continues to remain a strong predictor of morbidity and mortality in patients with chronic medical conditions [1, 2]. Cardiac transplantation is the gold standard treatment for end-stage heart failure. Patients with a condition so advanced as to require transplantation may experience pre/post-postoperative anxiety and depression [3–5]. The prevalence of major depressive disorder in patients on a heart transplant waiting list is almost 24%. Further increases in the intensity of the symptoms during the waitlisted period have also been reported [6, 7].

Although psychosocial risk factors are used to determine eligibility for placement on a heart transplant waiting list, few studies have examined the validity of such factors in predicting post-transplant outcomes. Several studies reported no association between psychosocial factors and mortality [9–12], while others have found that several psychiatric risk factors and social/demographic characteristics correlated with post-transplant morbidity [8]. As a result, the role of psychosocial factors on heart transplant outcomes requires further evaluation [13]. In this study we investigated the prognostic utility of “pre-transplant depression” on survival and morbidity after heart transplantation.

Patient data

This study was approved by our Institutional Review Board. It is a retrospective, study, examining 51 consecutive patients who underwent OHT at a single institution between 1999 and 2013. Relevant clinical data was extracted from United Network for Organ Sharing Transplant (UNOS), paper charts, and electronic medical records. Each patient had a full social worker psychosocial evaluation on record as part the preoperative transplantation work-up.

Social and demographic variables

Demographic variables included age, sex, race, citizenship and distance from the transplant center based on patient United States Postal Service zip code. All recipients underwent standardized evaluation by the heart transplant social worker. Social factors were defined as those variables that were present in the social history section of the assessment for transplant candidacy conducted by the transplant multidisciplinary team. These variables included each candidate’s marital status, employment status, access to phones, type of medical insurance, educational level, transplant readiness and the presence of social support. Any history of mental health problems, such as depression, bipolar disorder, anxiety, substance abuse (tobacco, alcohol and/or recreational drugs) was included. Patients were stratified by the presence or absence of depression during the initial visit using the self-scoring Beck Depression Inventory II. Depressed patients were further evaluated and treated by the psychiatry service. Inpatient and outpatient medical records were reviewed for antidepressant medication compliance.

Outcomes data

Survival data was obtained from the electronic medical record and UNOS data. Data on first hospitalization, overall hospitalizations, as well as cause of hospitalization (infection, rejection or other), compliance with outpatient follow-up appointments and medications was obtained. Rejection data regarding both acute cellular rejection and antibody mediated rejection were collected from biopsy data and electronic medical records. Hospitalizations for infections, defined as any hospitalization for documented fever, bacteremia, viremia, fungemia and pneumonia, were tabulated.

Statistical analysis

Pearson correlation coefficients were used on continuous variables. Independent t-tests and chi square-tests of independence were used to compare groups for continuous and discrete dependent variables respectively. A p-value of <0.05 was considered significant. Kaplan-Meier survival analysis was performed to distinguish survival in the two groups.

Fifty-one patients met inclusion criteria. Four patients who died within the first 30 days from acute graft failure and four other patients who transitioned their care to other centers after transplantation were excluded from the analysis. (Figure 1) of the 43 patients enrolled in our study, 9 patients (20.9%) were diagnosed with depression prior to OHT and 34 patients (79.1%) did not have depression. There was no significant difference in baseline characteristics of the two groups (Table 1). The depressed group had slight predominance of the female sex (44.5% vs. 23.5%, p = 0.219). Mean age was similar between two groups (57.5 ± 12.4 vs. 56.4 ± 12.3, p = 0.816). In both depressed and non-depressed groups, patient were predominantly African American (55.5% vs. 41.2%, p = 0.353), unemployed (88.9% vs. 91.2%, p = 0.861) and had a history of tobacco abuse (66.7% vs. 70.6%, p = 0.822).

Fig. 1

Study Design

Table 1

Baseline Demographics and Clinical Data in Depressed and Non-Depressed Group of Patients

Depressed patients

Non-depressed patients

N = 9

N = 34

p

Age (years)

57.5 ± 12.4

56.4 ± 12.3

0.816

Gender

Male

55.5% (5)

76.5% (26)

0.219

Female

44.5% (4)

23.5% (8)

Race

Caucasian

33.3% (3)

35.3% (12)

0.353

African American

55.5% (5)

41.2% (14)

Hispanic

11.2% (1)

17.6% (6)

Asian

0

5.9% (2)

Partner Status

Partner

55.5% (5)

58.8% (20)

0.861

No Partner

44.5% (4)

41.2% (14)

Employment Status

Not Employed

88.9% (8)

91.2% (31)

0.836

Employed

11.1% (1)

8.8% (3)

Insurance Type

Government

66.7% (6)

61.7% (21)

0.789

Private

33.3% (3)

38.3% (13)

Prior Tobacco History

Yes

66.7% (6)

70.6% (24)

0.822

No

33.3% (3)

29.4% (10)

Prior Alcohol Abuse

Yes

33.3% (3)

58.8% (20)

0.178

No

66.7% (6)

41.2% (14)

Prior Illicit Drug Use

Yes

11.1% (1)

14.7% (5)

0.784

No

88.9% (8)

85.3% (29)

There was no difference in baseline characteristics between the two groups

Depressed patients, compared to the control group, had higher incidence of first year hospitalizations (4.7 ± 3.1 vs. 2.2 ± 1.9, p = 0.046), had higher overall number of hospitalizations during a follow up period (8.3 ± 4.4 vs. 4.6 ± 4.2, p = 0.025), and had a shorter time to first hospitalization post-transplant (25 (IQR17-39) vs. 100 (IQR 37–229), p = 0.001). Patients in the depressed cohort had higher number of admissions for infections (2.8 ± 1.3 vs. 1.5 ± 1.4, p = 0.018) (Table 2, Fig. 2). Patients with a pre-transplant diagnosis of depression were 3.5 times more likely to be non-compliant with medications (RR = 3.5, 95% CI (1.2-10.2); p = 0.046). There was no difference in incidence of rejections or compliance with outpatient appointments. Kaplan-Meier survival analysis did not reveal any statistically significant difference in survival between the two groups (3705 vs. 3764 days, log rank p-value = 0.52)

Table 2

Clinical Outcomes in Transplant Recipients with and without Depression

Depressed patients

Non-depressed patients

N = 9

N = 34

P VALUE

Medication Compliance (%)

20.9

79.1

0.046

Time To First Hospitalization(Days)

25(IQR 17–39)

100(IQR 37–229)

0.001

First Year Hospitalizations

4.7 ± 3.1

2.2 ± 1.9

0.046

Overall Hospitalizations

8.3 ± 4.4

4.6 ± 4.2

0.025

Overall Infections

2.8 ± 1.3

1.5 ± 1.4

0.018

Overall Rejections

2.0 ± 1.5

1.2 ± 1.4

0.136

No Show Rate (%)

14 ± 6

12 ± 7

0.398

Overall Survival (Days)

3705

3764

0.52

Fig. 2

Clinical Outcomes in Transplant Recipients with and without Depression

Depression after cardiac surgery is well described [14]. Numerous studies have demonstrated an association between increased morbidity and mortality in depressed patients with concomitant cardiovascular disease compared to non-depressed patients [15–17]. Depression is a known marker of poor outcomes after transplant. The International Society of Heart and Lung Transplantation (ISHLT) recommends routine screening for depressive symptoms [18]. In our study we found that the outcomes between patients with and without pre-transplant depression did not differ in survival, total number of organ rejections, and compliance with outpatient appointments. Depressed patients had higher overall hospitalizations, higher number of first year hospitalizations and shorter time to hospitalization compared to the non-depressed cohort. Furthermore, depressed patients had higher rates of admission for infections and were more likely to be non-compliant with medications.

There is a high incidence of depression after OHT, often requiring regular screening and early intervention to be initiated during work up using validated tools such as the Beck Depression Inventory-II (BDI-II) or Patient Health Questionnaire 9 (PHQ-9) [6, 19, 20]. The BDI-II is a brief validated, easy to use scale which covers all DSM-IV diagnostic criteria for major depressive disorder, and stands as a reliable indicator of symptom severity and suicidal thoughts. BDI-II has high reliability and good correlation with measures of depression and anxiety [21].

The prevalence of pre-transplant depression in our cohort was 20.9%. This is slightly lower than the 26% observed by Okwuosa et al. [12], who examined the effects of depression in 102 post OHT patients. Similar to our findings, no statistically significant differences in survival between depressed and non-depressed patients were identified [12]. Okwuosa and al. concluded that all-cause hospitalizations were significantly higher in the depressed group, and demonstrated no difference in rejection episodes, severity of rejection between groups, or 5 year survival. These observations are in line with our findings.

Pre-existing depression is much more likely to persist into the post-transplant period [6], necessitating aggressive treatment in the pre-transplant period. Zipfel et al. showed severely depressed patients to be at increased risk of mortality after OHT [22]. As seen in our study, depressed patients are more likely to be non-compliant with prescribed medications, which can lead to adverse events in such high risk patient population [23–25]. A variety of published reports provide convincing evidence that occurrences of both compliance – related and psychiatric problems are relatively frequent and often unpredictable. [8, 26, 27]. It is well accepted that depressed patients respond to interventions such as psychotherapy and/or medications post transplantation. Royal et al. assessed the impact of antidepressant use after liver transplantation among patients with documented preoperative depression. Similar to our findings, no differences in survival and organ rejection were observed when comparing treated depressed with non-depressed groups [25].

Infection constitutes one of the more serious complications following OHT. Occurring predominantly within the first year after transplantation [28] infectious complications can account for up to 30% of deaths. This may partially be explained by the use of high dose immunosuppression early after transplantation. With reduction of immunosuppression in the following years, the number of infection related deaths decreases to 10% annually [29]. The reason for an increased number of infections in our depressed cohort is unknown. Paris and al. discovered a statistically significant association between psychiatric problems and risk of infection. Though, a causal association could not be ascribed [30]. In our study, patients with history of depression were more likely to be non-compliant, yet the incidence of rejection was similar between both groups. This may suggest that the immunosuppression regimen played a minor role.

Our study differs from the previous OHT studies in that it sheds light on the importance of pre-transplant evaluation and suggests that depressed patients represent a high-risk cohort that should be identified and managed more aggressively. Additionally, pre-transplant depression, if detected early and treated aggressively (with assistance of a transplant psychiatry/psychology team), does not necessarily portend a poor prognosis. However, despite treatment, these patients remain at a higher risk for morbidity in the post-transplant period and require aggressive 1) monitoring to ensure compliance, and 2) treatment to reduce subsequent hospitalizations.

Our results support the existing body of data suggesting that depression is associated with increased healthcare utilization [31]. It is imperative to identify these patients early. Initiation of appropriate treatment is expected to reduce resource utilization. Despite a relatively small sample size, our findings support a role for early, active intervention in depressed patients.

Study limitations

The retrospective nature of our study and relatively small sample size may limit the generalizability of these findings. However, all patients underwent standardized psychosocial evaluation performed by a heart transplant social worker prior to transplantation, minimizing potential selection bias. Since the depressed patients were later referred to different consultant psychiatrists, the potential for inter-observer variability must be considered (though, preoperatively all patients were evaluated by the same cardiac behavioral medicine team specializing in advanced heart failure and transplant patients). The retrospective nature further limits this study due to the possibility of the under-diagnosis of depression. It is possible that patients who developed depressive symptoms following OHT were not identified and as a result may have been categorized as non-depressed - further supporting the need for a prospective study that frequently assesses depressive symptoms.

No survival difference was identified when comparing depressed and non-depressed heart transplant recipients. Though, depressed patients were more likely to have increased number of hospitalizations and infections. A diagnosis of depression should not preclude OHT, but early identification and intervention must be occur. Additional larger prospective studies are needed to validate our findings.

Ethics approval and consent to participate

Manuscript conforms to IRB/ethics guidelines and has been approved by IRB/ethics committees.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.